Bavarian Nordic — Oktober 2019
-
Zealand Pharma brager over kurs 200 og sætter rekord på børsen
Biotekselskabet Zealand Pharmas aktie er for første gang mere end 200 kr. værd, efter at selskabet onsdag steg knap 11 pct. på børsen – tilsyneladende uden nyheder – og nåede en rekordhøj kurs.
-
"Uanset om gårsdagens stigning i Zealand Pharma skyldes fortsat værdivalidering af pipeline, delvis inddækning af shortsolgte positioner eller forventninger/håb/rygter om, at ZP på et tidspunkt kan blive en M&A kandidat, nyder investorerne opturen" https://www.proinvestor.com/?p=debat_1&postid=78477&thread=50&start=#78547
-
-
ZP:
"Sanofi Q3 well on track"
"Third-quarter and first nine months Soliqua
100/33 (insulin glargine 100 Units/mL & lixisenatide 33 mcg/mL injection) and Suliqua
sales increased 55% (to €33 million) and 72% (to €83 million), respectively."https://www.sanofi.com/en/media-room/press-releases/2019/2019-10-31-07-30-00
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind